Intervening Rights Defense Dooms Cancer Drug IP Claims

By Vin Gurrieri ( September 28, 2015, 6:33 PM EDT) -- BioDelivery Sciences International Inc. and two others dodged an infringement suit Friday related to the painkiller Onsolis, which is used to treat cancer patients, convincing a New Jersey federal judge that they're not liable for any infringement that occurred before two asserted patents were amended, under the intervening rights doctrine....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!